Alpha Tau Medical Ltd. (DRTS)
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company is headquartered in Jerusalem, Israel.
Sector: Surgical & Medical Instruments & Apparatus
Industry: Biotechnology
Alpha Tau Medical Ltd.
NASDAQ:DRTSHealthcare · Biotechnology
-1.28%$13.06
AH$13.06+0.00%vs close
Mkt Cap$1.21B
Float63.91M
O/S92.48M
Vol
$ Vol
RVOL
Inst Own8.6%
Earnings
Dilution
MCap$1.21B
Float63.91M
O/S92.48M
Dilution